OMSB approves list of doctors for scholarships
This came during its second meeting this year, chaired by Dr Hilal bin Ali al Sabti, Minister of Health and Chairman of the Board of Trustees.
The Board discussed the approval of the Basic Assessment and Support in Intensive Care (BASIC) training course, internal accreditation reports for specialised training programmes under the Adult Clinical Haematology Fellowship, and reviewed updates to the training programmes.
Additionally, the Board examined the self-assessment report for programmes in anaesthesiology, family medicine, orthopaedics and psychiatry. It also reviewed the Accreditation Council for International Healthcare Education (ACIHE)'s survey for trainers and trainees.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Muscat Daily
13-07-2025
- Muscat Daily
Royal Decree amends Social Protection Law
By OMAN NEWS AGENCY (ONA) Muscat – His Majesty Sultan Haitham bin Tarik issued Royal Decree No 60/2025 on Sunday amending some provisions of Royal Decree No 52/2023 on the promulgation of the Social Protection Law. It reads as follows: Article 1 states that the provisions of Clauses (2), (3) and (5) of Article (6) of Royal Decree No 52/2023 will be replaced with the following texts: The provisions of the branch on insurance for work injuries and occupational diseases for non-Omani workers under the attached law will come into force five years from the date of issuance of this decree. Chapter (6) of Part (3) of the attached law will come into force three years from the date of issuance of this decree. Clause (1) of Article (139) of the attached law will come into force on the date determined by the Board of Directors of the Social Protection Fund, provided it does not exceed four years from the date of issuance of this decree.
Observer
03-07-2025
- Observer
New strategy to boost pharma investments
The Omani government has unveiled a new strategic policy aimed at attracting investments into the country's pharmaceutical sector, with the dual objective of strengthening drug security and reducing reliance on imports. Despite some recent gains, the gap between local pharmaceutical production and import dependency remains significant. As of end-December 2023, locally manufactured pharmaceuticals accounted for just 4.6% of total medicine purchases, with imports making up the remaining 95.4%. However, national production capacity has shown encouraging growth — from a mere 1.8% in 2021 to 4.7% in 2022. According to Dr Hilal bin Ali al Sabti, Minister of Health (MoH), the new policy envisions the establishment of pharmaceutical manufacturing facilities within economic zones, free zones, and industrial cities, in line with Good Manufacturing Practices (GMP). Speaking to Duqm Economist, the newsletter of the Public Authority for Special Economic Zones and Free Zones (OPAZ), Dr Al Sabti said these zones offer a highly conducive environment, supported by advanced technical infrastructure, efficient regulatory frameworks, and integrated support services aligned with international standards. 'Industrial cities and special economic and free zones are attractive investment environments due to the financial incentives and regulatory facilitations they offer, including customs and tax exemptions. These advantages help lower production costs and enhance competitiveness,' he noted. Currently, eight pharmaceutical factories are operational in Oman: five fully integrated drug production facilities, two plants producing active pharmaceutical ingredients (APIs) for human medicines, and one facility focused on secondary packaging as an initial step in the production chain. While these factories are spread across industrial cities and free zones, the majority are located within industrial cities, which offer more advanced infrastructure and integrated services — factors that contribute to improved manufacturing quality and faster market availability. 'Measures are in place to support pharmaceutical factories in obtaining international accreditations such as GMP and ISO. Oman has a clear vision to position itself as a regional hub for pharmaceutical exports, in line with Oman Vision 2040,' the Minister stated. Dr Al Sabti affirmed that the Ministry is actively encouraging foreign direct investment (FDI) in the sector and promoting strategic partnerships with leading international pharmaceutical companies to facilitate technology transfer, localise production, and build domestic expertise. To this end, the Ministry is working to streamline registration and licensing procedures and is supporting public-private partnerships to foster an integrated and sustainable pharmaceutical manufacturing ecosystem. The aim, he said, is to drive innovation and ensure the availability of high-quality, efficient medical products. A key element of the new strategy is the fast-tracking of registration processes for locally manufactured medicines, supported by technical assistance throughout the regulatory cycle and accelerated quality testing to ensure safety and compliance. 'Recognising the strategic importance of this sector for national health security and self-sufficiency, the Ministry has established a robust regulatory framework in line with global standards. Through the Drug Safety Centre, we provide continuous technical support to manufacturers during planning, implementation, and licensing phases to ensure compliance with health and safety requirements. Locally manufactured medicines are given priority in the registration and evaluation process,' Dr Al Sabti added. The Ministry also welcomed projections of strong growth in Oman's pharmaceutical sector, underpinned by a pipeline of strategic projects targeting local production of sterile medicines, oncology drugs, and vaccines — key therapeutic categories that are central to achieving national drug security.
Observer
30-06-2025
- Observer
Taafi Centre to offer services for addicts
Muscat, June 30 The Ministry of Health celebrated the inauguration of the Muscat Taafi Centre, the main specialised facility in Oman to provide treatment and rehabilitation services for individuals recovering from addiction, in the Wilayat of Al Amerat, under the auspices of Sayyid Saud bin Hilal al Busaidy, Governor of Muscat, and in the presence of Dr Hilal bin Ali al Sabti, Minister of Health, and Dr Laila bint Ahmed al Najjar, Minister of Social Development. The centre is the first government institution in the Sultanate of Oman dedicated to the treatment and rehabilitation of addicts. It was established in collaboration with Petroleum Development Oman (PDO) and Al Jisr Foundation for Charitable Work, as part of a national vision to address the growing addiction issue and to provide comprehensive care in a safe and integrated environment. Dr Said bin Harib al Lamki, Under-Secretary of the Ministry of Health for Health Affairs, explained that the centre includes 170 beds — 40 for recovery and 130 for detoxification and medical and psychological rehabilitation. This reflects the scale of the project and the importance of its services. He pointed out that over 495 addiction cases were recorded in 2024, highlighting the urgent need for specialised centres like this one, which is designed to cover all stages of treatment: from detoxification to psychological rehabilitation, and finally to recovery and community support. Dr Al Lamki added that what distinguishes the centre is its integrative approach, bringing together the efforts of the Ministry of Health, the Ministry of Social Development, and the Royal Oman Police to provide comprehensive treatment under one roof — addressing the previous gap in psychological and rehabilitative services, which were formerly scattered among Al Masarra Hospital and other institutions. Dr Yousuf bin Mohammed al Farsi, Director-General of Health Services in Muscat Governorate, noted that the centre goes beyond medical treatment. It follows modern methods based on psychological and social rehabilitation in an interactive environment that includes artistic and skill-building activities such as drawing, reading and writing, as well as a private library and creative spaces. Dr Mahmood bin Zaher al Abri, Secretary of the National Committee for Narcotic Drugs and Psychotropic Substances, stated that Oman records an average of 480 addiction cases annually, with 52 per cent of them concentrated in Muscat Governorate, followed by Al Batinah North and Al Batinah South. He noted a worrying rise in the abuse of "shabu" (methamphetamine) since the Covid-19 pandemic, which causes psychotic symptoms and violent behaviours that may lead to suicide attempts. He also mentioned plans to develop an electronic system to document cases and ensure confidentiality, along with follow-up programmes in cooperation with the Ministry of Social Development. Aseela al Zaabi, Head of Muscat Taafi Centre, emphasised that the opening of the centre marks a qualitative leap in the provision of addiction treatment services in Oman. She pointed out that the services previously offered at Al Masarra Hospital have now been transferred to the new centre in Al Amerat, enhanced with more comprehensive and advanced facilities. It is worth noting that the total cost of the project amounted to RO 3.4 million — RO 2.5 million from PDO and RO 900,000 from Al Jisr Foundation. According to Dr Al Abri, the second phase of the centre will include an expansion to 300 beds, in addition to other centres under construction in Suhar and Dhofar. The opening of the centre represents a major step forward in building a comprehensive mental and physical health infrastructure in Oman and embodies an effective partnership between the public and private sectors to tackle one of the most serious health and social challenges of modern times.
